According to the latest report published by Credence Research, Inc. “Direct-to-Consumer Genetic Testing: Industry Growth, Future Prospects and Competitive Analysis, 2016-2022,” the direct-to-consumer genetic testing Industry was valued at USD 70.2 Mn in 2015, and is expected to reach USD 340 Mn by 2022, expanding at a CAGR of 25.1% from 2016 to 2022.
Conventionally, genetic tests have been made available only through healthcare providers at recommendations from physicians . Direct-to-consumer (DTC) genetic testing is defined as genetic teats Industryed directly to individuals through agencies such as internet, pharmacies and others. DTC genetic testing Industry is predominantly driven by growing awareness in public about genetic diseases, growing tendency to take proactive role in personal healthcare and the ongoing trend of understanding ancestral origins.
Browse the full report Direct-to-Consumer Genetic Testing Market @ http://www.credenceresearch.com/report/direct-to-consumer-genetic-testing-market
Since 2010, the prices of genome testing solutions have observed a sharp decline in prices and the Industry is mostly concentrated in the hands of a few Industry players. The utilization of genomic data is yet not perfected, however increasing researches and growing availability of these solutions will
pave way for further improvements in the business dynamics. On the other hand, notable risks such as vulnerability to misleading outcomes from unproven or invalid diagnosis, taking improper precautions or health decisions sans involvement of physician assistance and the associated repercussions may hold back the pace of this Industry. Another challenge to the Industry growth is potential risk of invasion of genetic privacy through unauthorized use of consumer data.
Genetic data services are roughly categorized into two sections namely, genome reading and interpretation of genomic data. The current Industry players mostly offer services that club the two categories into a single product. However some players have a differentiated their portfolio by offering DNA genotype as an individual product. Companies offering DTC genetic tests have varied portfolio and have varied revenue sources.
Request for Customization: http://www.credenceresearch.com/request-for-customization/57820
The global DTC genetic testing Industry is highly concentrated, with a handful of companies offering testing solutions. Some of the major players offering direct-to-consumer genetic testing solutions are 23andMe, MD Revolution, GeneByGene, DNA DTC, Genetrainer, Myriad Genetics, Genecodebook Oy and others.
Credence Research is a worldwide Industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US